Amicus Therapeutics, Inc. (FOLD)

14.24 +0.04 (+0.25%) USD  |  NASDAQ  |  Dec 24, 12:59
14.26 +0.02 (+0.11%) After-Hours: 13:59
More

Amicus Therapeutics CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for FOLD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
BioMarin Pharmaceutical, Inc. Upgrade
CorMedix, Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade